FDA president and Executive Committee elections 2020

Nominations are now open for the election of the FDA president and members of the FDA Executive Committee. As members of both the FDA and UNISON, MiP members are entitled to stand for election, nominate candidates and vote in both elections.
FDA Executive Committee
MiP has four seats on the FDA Executive Committee. MiP members can only nominate candidates from within the MiP constituency, and each nomination must be signed by at least two MiP members or by the MiP National Committee. If more than four candidates are nominated, a postal ballot will be held. Members elected to represent the MiP constituency will serve for a two-year term, from 1 June 2020 to 31 May 2022.
You can download the nomination form for the Executive Committee elections here.
FDA President
MiP members can also nominate candidates, from any constituency of the FDA, for the post of the FDA president. Candidates will need at least 30 nominations to stand, including at least five from three different constituencies. If more than one candidate is successfully nominated, a postal ballot will be held. The president will service a two-year term, from 1 June 2020 to 31 May 2022.
You can download the nomination form for the election of the FDA president here.
Nominations for both elections close at 5pm on Friday 6 March 2020.
You can read more about the FDA’s structure and the role of the president and Executive Committee on the FDA’s website.
Related News
-
MiP responds to the abolition of NHS England
Government risk repeating same mistakes as Lansley by abolishing NHS England and cutting more staff from ICBs, says MiP.
-
NHS England and central staff could be cut by 50%, NHSE has announced
Government planned cuts at NHS England go much further than previously announced, with up to 50% of staff at risk.
-
New MiP survey shows growing support for principle of regulating managers, but warns it won’t improve patient safety
MiP’s member survey on regulating NHS managers shows managers are still not convinced regulation will improve patient safety or raise standards, despite growing support for it in principle.